Stratos Wealth Partners LTD. Purchases New Position in Lam Research Co. (NASDAQ:LRCX)

Stratos Wealth Partners LTD. acquired a new position in shares of Lam Research Co. (NASDAQ:LRCX) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 108,703 shares of the semiconductor company’s stock, valued at approximately $7,852,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Atwood & Palmer Inc. purchased a new stake in Lam Research in the fourth quarter valued at approximately $27,000. West Oak Capital LLC increased its holdings in shares of Lam Research by 50.9% in the 4th quarter. West Oak Capital LLC now owns 400 shares of the semiconductor company’s stock valued at $29,000 after acquiring an additional 135 shares during the period. Country Trust Bank raised its position in Lam Research by 900.0% in the 4th quarter. Country Trust Bank now owns 400 shares of the semiconductor company’s stock valued at $29,000 after purchasing an additional 360 shares during the last quarter. Finley Financial LLC acquired a new stake in Lam Research during the 4th quarter worth $30,000. Finally, Stephens Consulting LLC grew its position in Lam Research by 900.0% during the 4th quarter. Stephens Consulting LLC now owns 430 shares of the semiconductor company’s stock worth $31,000 after purchasing an additional 387 shares during the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on LRCX shares. Morgan Stanley increased their target price on shares of Lam Research from $76.00 to $78.00 and gave the stock an “equal weight” rating in a research note on Thursday, December 5th. KeyCorp raised Lam Research from a “sector weight” rating to an “overweight” rating and set a $95.00 price objective for the company in a research report on Friday, January 17th. Needham & Company LLC restated a “buy” rating and set a $90.00 price target on shares of Lam Research in a research note on Thursday, January 30th. StockNews.com downgraded Lam Research from a “buy” rating to a “hold” rating in a report on Friday, October 11th. Finally, Barclays dropped their price objective on shares of Lam Research from $90.00 to $75.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Seven equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, Lam Research has a consensus rating of “Moderate Buy” and an average price target of $95.72.

Lam Research Stock Performance

NASDAQ:LRCX opened at $81.94 on Thursday. Lam Research Co. has a twelve month low of $68.87 and a twelve month high of $113.00. The company has a market capitalization of $105.18 billion, a P/E ratio of 24.89, a price-to-earnings-growth ratio of 1.34 and a beta of 1.46. The company has a current ratio of 2.54, a quick ratio of 1.73 and a debt-to-equity ratio of 0.51. The firm has a 50-day moving average price of $76.32 and a two-hundred day moving average price of $78.33.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. As a group, research analysts expect that Lam Research Co. will post 3.69 earnings per share for the current fiscal year.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.